News Search Results
Jun 04, 2025, 10:45 ET MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Loitering Munition Quadrant Report 2025
Arquimea is a technology-driven company committed to developing cutting-edge products and solutions across the aerospace and defense, biotechnology, and big science sectors. With a strong focus on solving complex societal challenges, the company reinvests a significant portion of its annual
More news about: MarketsandMarkets
Jun 04, 2025, 09:30 ET DPX Technologies Announces New Automated Workflows and Expanded Liquid Handler Compatibility for Genomic Testing
COLUMBIA, S.C., June 4, 2025 /PRNewswire/ -- DPX Technologies, a biotechnology company providing solutions for automated sample preparation, announces their latest products and fully automated workflows utilizing functionalized
More news about: DPX Technologies
Jun 04, 2025, 08:31 ET MetaVia Announces Poster Presentation on DA-1241 at the ADA's 85th Scientific Sessions
June 4, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a novel G-Protein-Coupled
More news about: MetaVia Inc.
Jun 04, 2025, 08:00 ET Repertoire Immune Medicines Appoints Robert Andtbacka, MD, CM, FACS, FRCSC, as Chief Medical Officer and Advances TCR Bispecific Development Candidate Toward the Clinic
Mass., June 4, 2025 /PRNewswire/ -- Repertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell-targeted immune medicines, today announced the appointment of Robert
More news about: Repertoire Immune Medicines
Jun 04, 2025, 07:41 ET SCbio Showcases South Carolina's Life Sciences Surge at Annual BIO Convention in Boston
BIO 2025, the annual international convention hosted by Biotechnology Innovation Organization June 16-19 in Boston.
More news about: SCbio
Jun 04, 2025, 05:38 ET BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Jun 04, 2025, 03:30 ET Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board
spent 34 years at Novo Nordisk, most recently as Corporate Vice President and Head of Biotechnology. During this time, he was responsible for building and heading a 240+ employee international protein-biotechnology organisation and he established the first international biopharmaceutical R&D centre
More news about: Commit Biologics
Jun 03, 2025, 18:54 ET BioVaxys Issues Corporate Update
to acquire the entire portfolio of assets and intellectual property based on the DPX immune educating platform technology developed by Canadian biotechnology company, IMV Inc. The May 2025 Amendment lowers a performance milestone provision in the original APA for BioVaxys
More news about: BioVaxys Technology Corp.
Jun 03, 2025, 18:29 ET FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Fortrea Class Action Lawsuit
global clinical research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. According to the complaint, in June 2023, Labcorp Holdings Inc. spun off Fortrea as
More news about: Robbins Geller Rudman & Dowd LLP
Jun 03, 2025, 17:31 ET Essential Thrombocythemia Market to Witness Robust Growth During the Forecast Period (2025-2034) Amid Rising R&D Activity | DelveInsight
same indication. By November 2022, Merck announced its acquisition of Imago BioSciences, a clinical-stage biotechnology company focused on bomedemstat for myelofibrosis treatment, for $36 per share in cash, totaling approximately
More news about: DelveInsight Business Research, LLP
Jun 03, 2025, 16:01 ET Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering
Immunic, Inc. ("Immunic" or the "Company") (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Jun 03, 2025, 11:21 ET ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis
founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific research platforms based on integrated, multidisciplinary technologies to enable life science research,
More news about: ThinkCyte Inc.
Jun 03, 2025, 11:14 ET ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis
founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific research platforms based on integrated, multidisciplinary technologies to enable life science research,
More news about: ThinkCyte Inc.
Jun 03, 2025, 10:30 ET Digital Pathology Market worth US$2.75 billion by 2030 with 13.5% CAGR | MarketsandMarkets™
slide retrieval, and simplified image collaboration and sharing to obtain second opinions. By end user, the pharmaceutical & biotechnology companies segment dominated the market in 2024 due to growing drug research, discovery, and personalized medicine use of digital pathology. Digital
More news about: MarketsandMarkets
Jun 03, 2025, 10:27 ET Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach
Nature Biotechnology article in March 2024. About Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary
More news about: Insilico Medicine
Jun 03, 2025, 10:18 ET Medical Writing Market Size to Grow at 10.46% CAGR, Globally, by 2030 - Exclusive Report by The Research Insights
the medical writing market size is divided into medical device/pharmaceutical & biotechnology companies and contract research organizations (CROs) & others. The medical device/pharmaceutical & biotechnology companies segment accounted for a larger share of the medical writing market revenue
More news about: The Research Insights
Jun 03, 2025, 10:00 ET AmplifyeP24 Can Double Protein Absorption with One Daily Capsule
Amplifye, a biotechnology company specializing in enhancing protein nutrition through the development of proprietary enzymes, today announces the launch of its first consumer
More news about: Amplifye
Jun 03, 2025, 09:30 ET Kytopen Elects Industry Veterans to Board, Further Demonstrating its Commitment to Enabling Advanced Engineered Cell Therapy Workflows
across a range of cell types, payloads, and therapeutic applications. Kytopen has recently disclosed strategic partnerships with industry-leading biotechnology companies, contract development and manufacturing organizations (CDMOs), and cell therapy-focused medical centers. Kytopen continues to engage strategic
More news about: Kytopen
Jun 03, 2025, 09:00 ET Congruence Therapeutics Announces Oral Presentation on Novel GCase Activators and Correctors for Parkinson's Disease with GBA1 Mutations at the GBA1 Meeting 2025
June 3, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic obesity, GBA-driven Parkinson's
More news about: Congruence Therapeutics
Jun 03, 2025, 08:00 ET Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies
CDMO space. Acquired capabilities include cutting-edge biologics development and manufacturing services to serve the needs of global innovative biotechnology companies. AHMEDABAD, India and PENNINGTON,
More news about: Zydus Lifesciences
Jun 03, 2025, 07:25 ET Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its CEO, Dr. Amit Kumar, was interviewed
More news about: Anixa Biosciences, Inc.
Jun 03, 2025, 07:00 ET Genprex to Participate at BIO 2025 International Convention
[email protected]. The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. About Genprex, Inc.Genprex,
More news about: Genprex, Inc.
Jun 03, 2025, 05:29 ET FTRE Stockholder Alert: Robbins LLP Informs Investors of the Fortrea Holdings, Inc. Class Action Lawsuit
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers.
More news about: Robbins LLP
Jun 02, 2025, 21:00 ET XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson's Diseases, Spinal Cord Injury and ALS
2, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has received seven Investigational New Drug
More news about: XellSmart
Jun 02, 2025, 21:00 ET Sony, SCREEN, and VitroVo to Start Trial Offer of MEA System Capable of Simultaneous Measuring and Recording Data from Approximately 237,000 Electrodes
the single-cell level. It has also shown promise for applications not only in drug discovery but also in a wide variety of disciplines such as biotechnology, biomedical science, medicine, and pharmacology. The results of their research have also been applied to the development of the system.Related
More news about: Sony Semiconductor Solutions Corporation